Interaction of C1 inhibitor with thrombin on the endothelial surface

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 7, 2011, Pages 571-575

  Caccia, Sonia ^a   Castelli, Roberto ^a   Maiocchi, Diana ^a   Bergamaschini, Luigi ^a   Cugno, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

C1 inhibitor; endothelium; human umbilical vein endothelial cells; thrombin

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; HEPARIN; HEPARIN LYASE; MONOCLONAL ANTIBODY; SELECTIN; THROMBIN;

ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONCENTRATION (PARAMETERS); ENDOTHELIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PURIFICATION;

ANTIBODIES, MONOCLONAL; BLOOD COAGULATION; CAPILLARY PERMEABILITY; CELLS, CULTURED; COMPLEMENT C1 INHIBITOR PROTEIN; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HEPARIN; HEPARIN LYASE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KINETICS; PROTEIN BINDING; SELECTINS; THROMBIN;

EID: 80053597917     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283494ba7     Document Type: Article

References (27)

1. Davis AE III. C1 inhibitor and hereditary angioneurotic edema. Ann Rev Immunol 1988; 6:595-628.
2. Harpel PC, Cooper NR. Studies on human plasma C1-inactivator-enzyme interaction I. Mechanisms of interaction with C1 s, plasmin and trypsin. J Clin Invest 1975; 55:593-604.
3. Arlaud G, Reboul A, Sim R, Colomb M. Interaction of C1 inhibitor with the C1r and C1s subcomponents in human C1. Biochim Biophys Acta 1979; 576:151-162. (Pubitemid 9086866)
4. Wuillemin WA, Eldering E, Citarella F, de Ruig CP, ten Cate H, Hack CE. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa. J Biol Chem 1996; 271:12913-12918. (Pubitemid 26175865)
5. Gigli I, Mason JW, Colman RW, Austen KF. Interaction of plasma kallikrein with the C1 inhibitor. J Immunol 1970; 104:574-581.
6. Schreiber AD, Kaplan AP, Austen KF. Inhibition of C1-inhibitor of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest 1973; 52:1402-1409.
7. Van Nostrand WE, McKay LD, Baker JB, Cunningham DD. Functional and structural similarities between protease nexin I and C1 inhibitor. J Biol Chem 1988; 263:3979-3983. (Pubitemid 18078995)
8. Garcia JGN, Siflinger-Birnboim A, Bizios R, Del Vecchio PJ, Fenton JW III, Malik AB. Thrombin induced increase in albumin permeability across the endothelium. J Cell Physiol 1986; 128:96-104. (Pubitemid 16099466)
9. Garcia JGN, Pavalko FM, Patterson CE. Vascular endothelial cell activation and permeability responses to thrombin. Blood Coagul Fibrinolysis 1995; 6:609-626.
10. Kondo N, Ogawa M, Wada H, Nishikawa S. Thrombin induces rapid disassembly of claudin-5 from the tight junction of endothelial cells. Exp Cell Res 2009; 315:2879-2887.
11. Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A. Activation of the coagulation cascade in C1 inhibitor deficiencies. Blood 1997; 89:3213-3218.
12. Cugno M, Zanichelli A, Bellatorre AG, Griffini S, Cicardi M. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy 2009; 64:254-257.
13. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A. Plasma bradykinin in angioedema. Lancet 1998; 351:1693-1697.
14. Ehringer WD, Edwards MJ, Miller FN. Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J Cell Physiol 1996; 167:562-569. (Pubitemid 26168232)
15. Cugno M, Bos I, Lubbers J, Erik Hack C, Agostoni A. In vitro interaction of C1-inhibitor with thrombin. Blood Coagul Fibrinolysis 2001; 12:253-260. (Pubitemid 32575157)
16. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 1997; 99:2062-2070. (Pubitemid 27203760)
17. Cai S, Davis AE III. Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol 2003; 171:4786-4791. (Pubitemid 37310598)
18. Pilatte Y, Hammer CH, Frank MM, Fries LF. A new simplified procedure for C1 inhibitor purification. A novel use for jacalin-agarose. J Immunol Methods 1989; 120:37-43. (Pubitemid 19144193)
19. Bergamaschini L, Gobbo G, Gatti S, Caccamo L, Prato P, Maggioni M, et al. Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol 2001; 126:412-420. (Pubitemid 34008711)
20. Preissner KT. Anticoagulant potential of endothelial cell membrane components. Haemostasis 1988; 18:271-300.
21. Esmon CT, Esmon NL. The link between vascular features and thrombosis. Annu Rev Physiol 2011; 73:7.1-7.12.
22. CuerrierCM, GagnerA,LebelR,GobeilFJr,GrandboisM.Effectofthrombin and bradykinin on endothelial cell mechanical properties monitored through membrane deformation. J Mol Recognit 2009; 22:389-396.
23. Levi M, Nieuwdorp M, van der Poll T, Stroes E. Metabolic modulation of inflammation-induced activation of coagulation. Semin Thromb Hemost 2008; 34:26-32. (Pubitemid 351640879)
24. Caliezi CW, Wuillemin A, Zeerleder S, Redondo M, Eisele B, Hack CE. C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 2001; 52:91-112. (Pubitemid 30127596)
25. Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009; 15:69-78.
26. Castelli R, Deliliers DL, Zingale LC, Pogliani EM, Cicardi M. Lymphoproliferative disease and acquired C1 inhibitor deficiency. Haematologica 2007; 92:716-718. (Pubitemid 350144284)
27. Cugno M, Bergamaschini L, Uziel L, Cicardi M, Agostoni A, Jie AF, Kluft C. Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency). J Clin Chem Clin Biochem 1988; 26:423-427.